西南证券维持九洲药业买入评级：业绩延续高增长，CDMO业务持续加速

七印授权

37J4RAPOQPRAPJOC9FH3TS87IP4YGDUB4B1Q5VT7AQ8ZY07443

2023-01-23 14:08:14

article

BF8BD8313645935CE41623EF3D709EEBEEFFDEF146567C2C5BB7EF324EF5BA48

zh-CN

4923CFCD2C90249044AAB7420DC1644D9EAE543A

13998406

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

e637e1fb43778f4f7c7b97b7993e378857e04653f9e9fa44cbee85104ca0938e4577d1b467eae0240deb55feae26387c8ddd0271a6e86633446763873dc2e15d1c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"100000"},"type":"cm"}

yuanben_63ce94ced139b6.07778401

原本认证

52HU0J4904FTLZ6LGHWLJYFRZLRFTEWDQZGJ5GVKL1CCHX5JB4

https://www.yuanben.io/article/18a567d9-4e14-4596-ac4b-8499d645d68b

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}